These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20596746)

  • 1. Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.
    Weinreich J; Schott S; Königsrainer I; Zieker D; Königsrainer A; Schott H
    Invest New Drugs; 2011 Dec; 29(6):1294-302. PubMed ID: 20596746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites.
    Weinreich J; Struller F; Küper M; Hack A; Königsrainer A; Schott TC
    Anticancer Drugs; 2013 Apr; 24(4):375-83. PubMed ID: 23358120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.
    Schott S; Wallwiener M; Kootz B; Seeger H; Fehm T; Neubauer H
    Invest New Drugs; 2011 Jun; 29(3):506-13. PubMed ID: 19997962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding.
    Schott H; Schott S; Schwendener RA
    Bioorg Med Chem; 2009 Oct; 17(19):6824-31. PubMed ID: 19744858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells.
    Schott S; Niessner H; Sinnberg T; Venturelli S; Berger A; Ikenberg K; Villanueva J; Meier F; Garbe C; Busch C
    Int J Cancer; 2012 Nov; 131(9):2165-74. PubMed ID: 22323315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.
    Eicher C; Dewerth A; Ellerkamp V; Fuchs J; Schott S; Armeanu-Ebinger S
    Pediatr Surg Int; 2013 Feb; 29(2):121-7. PubMed ID: 23187893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and Chemosensitivity of Gastric Adenocarcinoma and Non-Malignant Cell Lines in Response to Novel Anti-Cancer Drug Combinations.
    Weinreich J; Archid R; Bajaeifer K; Hack A; Königsrainer A; Schott TC
    Chemotherapy; 2014; 60(5-6):346-52. PubMed ID: 26314695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine.
    Novotny L; Rauko P; Schott H
    Anticancer Res; 2010 Dec; 30(12):4891-8. PubMed ID: 21187467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
    Weinreich J; Struller F; Sautkin I; Giuashvili S; Reymond M; Königsrainer A; Schott TC
    Invest New Drugs; 2019 Jun; 37(3):415-423. PubMed ID: 30019100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.
    Fukushima H; Abe T; Sakamoto K; Tsujimoto H; Mizuarai S; Oie S
    BMC Cancer; 2014 Aug; 14():562. PubMed ID: 25087851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and mechanism of action of a duplex and multidrug of ethynylcytidine and 5-fluorodeoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Schott S; Fichtner I; Honeywell RJ; Losekoot N; Laan AC; Peters GJ
    Nucleic Acids Symp Ser (Oxf); 2008; (52):651. PubMed ID: 18776548
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells
    Schott S; Wimberger P; Klink B; Grützmann K; Puppe J; Wauer US; Klotz DM; Schröck E; Kuhlmann JD
    Oncotarget; 2017 Sep; 8(44):76935-76948. PubMed ID: 29100359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.
    Evans TR; Pentheroudakis G; Paul J; McInnes A; Blackie R; Raby N; Morrison R; Fullarton GM; Soukop M; McDonald AC
    Ann Oncol; 2002 Sep; 13(9):1469-78. PubMed ID: 12196374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd).
    Wataya Y; Futagami M; Naito T; Uchikubo Y; Yokogawa T; Takenaka K; Kim HS; Matsuda A; Fukushima M; Kitade Y
    Nucleic Acids Res Suppl; 2001; (1):233-4. PubMed ID: 12836350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma.
    Bichev D; Treese C; von Winterfeld M; Breithaupt K; Dogan Y; Schmidt SC; Daum S; Thuss-Patience PC
    Oncology; 2015; 89(2):95-102. PubMed ID: 25823985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Wengel J
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):397-400. PubMed ID: 16247958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
    Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Fichtner I; Smid K; Laan AC; Schott S; Losekoot N; Honeywell RJ; Peters GJ
    Invest New Drugs; 2011 Apr; 29(2):248-57. PubMed ID: 19957099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L.
    Naito T; Yokogawa T; Kim HS; Matsuda A; Sasaki T; Fukushima M; Kitade Y; Wataya Y
    Nucleic Acids Symp Ser (Oxf); 2006; (50):103-4. PubMed ID: 17150838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.